IQVIA Reports First-Quarter 2025 Results

About this update from Iqvia Holdings, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":240,"url":"https://media.zenfs.com/en/business-wire.com/eb48881619f514b68141705699341baf"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Qpn6iKkyZF_Y1r3cvVfazg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/eb48881619f514b68141705699341baf","width":480,"height":240}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue of $3,829 million","length":25,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"GAAP Net Income of $249 million, Adjusted EBITDA of $883 million","length":64,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"GAAP Diluted Earnings per Share of $1.40, Adjusted Diluted Earnings per Share of $2.70","length":86,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"R&D Solutions quarterly bookings of $2.1 billion, resulting in trailing-twelve-month bookings of $9.7 billion and a trailing-twelve-month book-to-bill ratio of 1.14x","length":169,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"R&D Solutions contracted backlog of $31.5 billion, up 4.8 percent year-over-year","length":84,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"TAS Revenue of $1,546 million, up 6.4 percent reported year-over-year and 7.6 percent at constant currency","length":106,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Operating Cash Flow of $568 million and Free Cash Flow of $426 million, up 13 percent year-over-year, representing 89 percent of Adjusted Net Income","length":148,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Repurchased $425 million of common stock","length":40,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Raised full-year revenue guidance by $275 million to reflect more favorable foreign currency exchange rates; reaffirmed profit guidance","length":135,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":857,"olType":false},{"type":"text","content":"RESEARCH TRIANGLE PARK, N.C., May 06, 2025--(BUSINESS WIRE)--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelli...

More updates from Iqvia Holdings, Inc.